Hub Dialogues: Durhane Wong-Rieger on rare disorders and the risks of single-payer pharmacare

Durhane Wong-Rieger, the president and CEO of the Canadian Organization for Rare Disorders, discusses the challenges that Canadians with rare disorders face in getting access to drugs and the risk that single-payer pharmacare exacerbates them by focusing too much on cost control and too little on the benefits of personalized medicine.This episode was made possible by the Canadian Life and Health Insurance Association and the generosity of listeners like you. Donate today.The Hub Dialogues features The Hub's editor-at-large, Sean Speer, in conversation with leading entrepreneurs, policymakers, scholars, and thinkers on the issues and challenges that will shape Canada's future at home and abroad.If you like what you are hearing on Hub Dialogues consider subscribing to The Hub's free weekly email newsletter featuring our insights and analysis on key public policy issues. Sign up here: https://thehub.ca/free-member-sign-up/. Hosted on Acast. See acast.com/privacy for more information.